STOCK TITAN

[SCHEDULE 13D/A] ACCURAY INC Amended Major Shareholder Report

ACCURAY INC (symbol: ARAY) is the issuer of record for a Form SCHEDULE 13D/A filing submitted to the SEC.

(Moderate)
(Neutral)
Form Type
SCHEDULE 13D/A

Rhea-AI Filing Summary

ACCURAY INC (symbol: ARAY) is the issuer of record for a Form SCHEDULE 13D/A filing submitted to the SEC.

Positive

  • None.

Negative

  • None.

Filing Explained

Accuray received $15.0 million and issued penny warrants; the $55.0 million preferred financing remains unclosed, so its common-share conversion is not yet issued.

A Schedule 13D/A tracks a holder's above-5% ownership and, unlike a passive Schedule 13G, is used when the holder may seek to influence control; this amendment reports TCW's financing-linked stake and governance rights.

The July 29 Purchase Agreement is signed but its closing has not occurred: the Series A Preferred Stock is not outstanding, while the issuer has already issued two July Penny Warrants and the $15.0 million cash investment was paid at signing.

The planned financing totals $55.0 million, split between that $15.0 million cash investment and conversion of $40.0 million of existing debt at closing, subject to closing conditions. If issued, 55,000 preferred shares would initially convert at 2,000 common shares per $1,000 of stated value, or $0.50 per share, and TCW would have rights to designate up to two directors and require committee representation.

TCW reports shared voting and dispositive power over 27,527,916 common shares issuable under warrants, representing 18.7% on a basis of 119,439,307 outstanding shares plus those issuable shares. The July Penny Warrants cover 7,987,743 and 598,114 shares, carry a $0.01 exercise price, and expire on July 29, 2033; if exercised, issuing those shares would increase total shares and reduce existing holders' percentage ownership absent offsetting changes. The preferred issuance would also trigger cancellation of specified Premium, Super Premium, and December Premium Warrants, but only upon closing. The next structural checkpoints are the financing closing and stockholder approval: if the purchase is terminated or approval is not obtained, the $15.0 million cash investment becomes secured debt and a $15.0 million fee is payable under the stated repayment triggers.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates





If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




schemaVersion:


SCHEDULE 13D




Comment for Type of Reporting Person:
(1) The calculation of the percentage of beneficial ownership is based on (i) 119,439,307 shares of Common Stock (as defined below) outstanding as of August 21, 2026 as disclosed in the Annual Report on Form 10-K for the year ended June 30, 2026 of Accuray Incorporated (the "Issuer"), as filed with the Securities and Exchange Commission (the "SEC") on August 27, 2026, plus (ii) 27,527,916 shares of Common Stock issuable upon exercise of the Warrants and the July Penny Warrants (as defined below).


SCHEDULE 13D


The TCW Group, Inc., on behalf of the TCW Business Unit
Signature:/s/ Andrew Bowden
Name/Title:Andrew Bowden, Executive Vice President
Date:09/02/2026